indoximod
Showing 1 - 8 of 8
Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)
Recruiting
- Ependymoma
- +3 more
- Ibrutinib
- +3 more
-
Augusta, GeorgiaAugusta University, Georgia Cancer Center
Dec 16, 2022
Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose
Recruiting
- Glioblastoma
- +3 more
- Indoximod
- +6 more
-
Augusta, Georgia
- +2 more
Aug 18, 2022
NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)
Terminated
- Non-small Cell Lung Cancer
- +2 more
- Docetaxel
- +2 more
-
Saint Louis, Missouri
- +1 more
Apr 4, 2022
Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Conformal Radiation)
Completed
- Glioblastoma Multiforme
- +7 more
- Indoximod
- +4 more
-
Aurora, Colorado
- +4 more
Jun 3, 2020
Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)
Completed
- Metastatic Melanoma
- +2 more
- Indoximod
- +3 more
-
Augusta, Georgia
- +5 more
Jun 3, 2020
Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer Trial in United States (Nab-Paclitaxel, Gemcitabine,
Completed
- Metastatic Pancreatic Adenocarcinoma
- Metastatic Pancreatic Cancer
- Nab-Paclitaxel
- +2 more
-
Palo Alto, California
- +10 more
May 26, 2020
Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)
Completed
- Glioblastoma Multiforme
- +3 more
- Indoximod
- +3 more
-
Castro Valley, California
- +16 more
May 26, 2020